Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | POU3F2 |
| Upstream (Parents) |
|---|
| (<<) ATF5 → POU3F2 |
| (<<) TLX3 → POU3F2 |
| (<<) KDM5B → POU3F2 |
| (<<) BARX1 → POU3F2 |
| (<<) SIX1 → POU3F2 |
| (<<) MYF5 → POU3F2 |
| (<<) KLF9 → POU3F2 |
| (<<) PHF1 → POU3F2 |
| (<<) MEF2C → POU3F2 |
| (<<) TBX10 → POU3F2 |
| (<<) NKX3-1 → POU3F2 |
| (<<) CREBBP → POU3F2 |
| (<<) TBX3 → POU3F2 |
| Downstream (Children) |
|---|
| POU3F2 → ASCL1 (>>) |
| POU3F2 → NANOG (>>) |
| POU3F2 → POU6F2 (>>) |
| POU3F2 → SMAD3 (>>) |
| POU3F2 → TBR1 (>>) |
| POU3F2 → NFATC1 (>>) |
| POU3F2 → TBX4 (>>) |
| POU3F2 → HOXB1 (>>) |
| POU3F2 → FOXL1 (>>) |
| POU3F2 → ESRRA (>>) |
| POU3F2 → JUND (>>) |
